What We Do

Lilly unites caring with discovery to make life better for people around the world. We focus on a number of core global business areas including bio-medicines/speciality care, diabetes and oncology. We also continue to pursue innovative science and new opportunities beyond our targeted disease categories.

Bio-Medicines and Speciality Care
Lilly Bio-Medicines and Specialty Care includes the therapeutic areas of autoimmunity, neuroscience and cardiovascular medicine. Some of our most recent research has focused on immunotherapy and has delivered new treatments in dermatology and rheumatology.

Lilly remains committed to meeting the needs of people with diabetes; from medicines to support programmes, including investing in one of our largest diabetes pipelines ever.

As one of the top oncology companies in the world, Lilly focuses on speeding innovation and improving outcomes for individual patients, and boasts one of the largest clinical pipelines in the oncology industry.